Soleus Capital is a private equity firm.
Soleus Capital is a private equity firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 7, 2021
Freenome
|
Series D | $300M | Biotechnology | — |
May 27, 2021
Genapsys
|
Series D | $70M | Bioinformatics | — |
May 5, 2021
NeoGenomics
|
Post-IPO Equity | $200M | Biotechnology | — |
Nov 25, 2020
SomaLogic
|
Series A | $121M | Biotechnology | — |
Aug 26, 2020
Freenome
|
Series C | $270M | Biotechnology | — |